Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New System Enables Multi-Color Resolution in Cells

By LabMedica International staff writers
Posted on 05 Jun 2017
A powerful microscope imaging system provides five times more speed and an increased viewing area up to 10,000 times, which can be combined with a new photomanipulation scanner to activate, ablate, and bleach cells or molecules within one experiment.

The Leica (Wetzler, Germany) DMi8 S imaging system was launched at the 17th International European Light Microscopy Initiative Meeting (ELMI) that was held in Dubrovnik, Croatia, May 23-26, 2017.

The imaging system is based on the DMi8 modular research microscope. More...
This advanced instrument is fully configurable with manual or motorized accessories, and the system can be adapted or upgraded at any time. The Leica DMi8 was designed with flexibility in mind. With up to two Infinity Ports providing access points for addition of fluorescent devices, the microscope is easily adaptable for applications ranging from simple fluorescent imaging to sophisticated super resolution techniques. This novel design facilitates the integration of additional fluorescence light sources and laser systems for advanced applications like FRAP (fluorescence recovery after photobleaching), photo-switching, ablation, optogenetics, and more.

With the highly flexible Infinity TIRF (total internal reflection fluorescence) module, researchers can produce simultaneous multicolor illumination, and by employing the high power illumination option, perform super resolution applications. These options enable the researcher to achieve multi-color single molecule resolution at the cell surface to resolve structures involved in receptor trafficking, synaptic organization, or cell adhesion. With the high-powered lasers option, it is possible to image and analyze samples down to a resolution of 20 nanometers.

“Live-cell imaging is the future in discoveries. Gaining insight on dynamic processes is key to understand the mechanisms, potential treatments, and prevention of human diseases,” said Markus Lusser, president of Leica Microsystems. “These new DMi8 S developments have far reaching utility. Whether studying neuroscience, cancer, or immunology, researchers can use the DMi8 S to get elusive answers to their questions and find the links to our complex biology.”


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.